Invesco India Pharma And Healthcare Fund Direct-Growth
Riskometer 
Very High
Value Research Opinion
New Fund
—
Returns
Risk
This fund has Very High risk.
As per SEBI's Riskometer.
Portfolio of Invesco India Pharma And Healthcare Fund Direct-Growth
Asset Allocation
Split between different types of investments
Market Cap Weightage
Split between categories of Equity investments
Other details of Invesco India Pharma And Healthcare Fund Direct-Growth
Assets
₹-- Cr
Exit Load (Days)
0.50 (90)
Min. Investment (₹)
1,000
Min. Withdrawal (₹)
1,000
Min. SIP Investment (₹)
100
Min. No of Cheques
12
About Invesco India Pharma And Healthcare Fund Direct-Growth
Invesco India Pharma And Healthcare Fund Direct-Growth is a equity mutual fund scheme of Invesco Mutual Fund. Launched on September 01, 2026, it is currently managed by Aditya Khemani. The fund has an expense ratio of --% with an overall AUM (Assets Under Management) of ₹-- Cr.
Invesco India Pharma And Healthcare Fund - Direct Plan is mandated to invest at least 80 per cent of its assets in the shares of pharmaceutical and healthcare companies. The fund allows minimum lumpsum investment of ₹1,000 and minimum SIP of ₹100.
Suitability
Pharma funds are suitable for investors:
- Wanting a small, supporting exposure to the pharmaceutical and healthcare sector
- Aiming for long term wealth creation
- With a 7+ year investment horizon, who can withstand the sharper swings of a concentrated portfolio
Note:
- Most investors can skip these funds and stick to diversified equity funds instead
- If you choose to invest, do so only through SIP
FAQ for Invesco India Pharma And Healthcare Fund Direct-Growth
How to Invest in Invesco India Pharma And Healthcare Fund Direct-Growth?
Subscribers of Value Research Fund Advisor can conveniently invest in the low-cost direct plan of Invesco India Pharma And Healthcare Fund Direct-Growth through the Value Research Fund Advisor website.
Alternatively, mutual funds can also be purchased directly from the respective fund house’s website. For example, Invesco India Pharma And Healthcare Fund Direct-Growth can be bought from the Invesco Mutual Fund website. In such a case, if you are investing in multiple funds from different fund houses, you will need to transact separately on each fund house’s website.
The third option is to invest offline, by seeking assistance from a mutual fund distributor. Most banks also act as mutual fund distributors, and you can approach your bank for help in completing your investment.
What is the return of Invesco India Pharma And Healthcare Fund Direct-Growth in the last 5 years?
Over the past five years, Invesco India Pharma And Healthcare Fund Direct-Growth has delivered an annualised return of % as of 15-Aug-2026.
What is the minimum investment required in Invesco India Pharma And Healthcare Fund Direct-Growth?
The minimum investment required to start investing in Invesco India Pharma And Healthcare Fund Direct-Growth is ₹1,000 for the lump sum option and ₹100 for the SIP (Systematic Investment Plan) option.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.